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Letter

An ∼140-kb deletion associated with feline spinal
muscular atrophy implies an essential LIX1 function
for motor neuron survival
John C. Fyfe,1,7,8 Marilyn Menotti-Raymond,2,7 Victor A. David,2 Lars Brichta,3
Alejandro A. Schäffer,4 Richa Agarwala,4 William J. Murphy,5 William J. Wedemeyer,6
Brittany L. Gregory,1 Bethany G. Buzzell,2 Meghan C. Drummond,1 Brunhilde Wirth,3
and Stephen J. O’Brien2
1

Laboratory of Comparative Medical Genetics, Department of Microbiology & Molecular Genetics, College of Veterinary Medicine,
Michigan State University, East Lansing, Michigan 48824, USA; 2Laboratory of Genomic Diversity, National Cancer
Institute–Frederick, Frederick, Maryland 21702, USA; 3Institute of Human Genetics, Institute of Genetics, and Center for
Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany; 4National Center for Biotechnology Information,
National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20894, USA; 5Department of
Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College
Station, Texas 77843, USA; 6Department of Biochemistry & Molecular Biology, Michigan State University,
East Lansing, Michigan 48824, USA
The leading genetic cause of infant mortality is spinal muscular atrophy (SMA), a clinically and genetically
heterogeneous group of disorders. Previously we described a domestic cat model of autosomal recessive,
juvenile-onset SMA similar to human SMA type III. Here we report results of a whole-genome scan for linkage in the
feline SMA pedigree using recently developed species-specific and comparative mapping resources. We identified a
novel SMA gene candidate, LIX1, in an ∼140-kb deletion on feline chromosome A1q in a region of conserved synteny
to human chromosome 5q15. Though LIX1 function is unknown, the predicted secondary structure is compatible with
a role in RNA metabolism. LIX1 expression is largely restricted to the central nervous system, primarily in spinal
motor neurons, thus offering explanation of the tissue restriction of pathology in feline SMA. An exon sequence
screen of 25 human SMA cases, not otherwise explicable by mutations at the SMN1 locus, failed to identify
comparable LIX1 mutations. Nonetheless, a LIX1-associated etiology in feline SMA implicates a previously undetected
mechanism of motor neuron maintenance and mandates consideration of LIX1 as a candidate gene in human SMA
when SMN1 mutations are not found.
[Supplemental material is available online at www.genome.org. The sequence data from this study has been submitted
to GenBank under accession no. DQ250154.]
The spinal muscular atrophies (SMAs) are a genetically heterogeneous group of disorders that vary in clinical severity, from
lethal in infancy to onset of mild weakness in adulthood, but all
are characterized by neurogenic muscle atrophy due to degeneration of lower motor neurons of the spinal cord (Talbot and
Davies 2001). The autosomal recessive SMAs with primary involvement of proximal musculature occur in one per 6000–
10,000 live births and are the leading genetic cause of infant
mortality (Pearn 1978; Ogino and Wilson 2002). The International SMA Consortium categorized proximal SMA by age of onset and clinical severity into types I through III (Munsat and
Davies 1992). In studies restricted to well-characterized proximal
SMA patients, ∼97% show either deletions, gene conversions, or
other subtle mutations in the telomeric copy of the survival of
motor neuron gene 1 (SMN1), whereas the remaining ∼3% fail to
7
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show any mutation in SMN1 (Lefebvre et al. 1995; Wirth et al.
1999; Wirth 2000). The latter category of patients with proximal
SMA is usually characterized by two copies of SMN1 and most
often exhibit the less severe phenotype categorized as type III
(Wirth et al. 1999).
The high incidence of human SMA is mainly due to a human-specific (Rochette et al. 2001), inverted duplication of 500
kb on human chromosome (HSA) 5q13 that predisposes the
SMN1 locus to de novo deletion and gene conversion events
through interactions with the divergent and only partially functional centromeric copy of the gene (SMN2) (Wirth et al. 1997).
The two copies of SMN differ in five nucleotide exchanges, only
one of which is located in the coding region, and although it is
translationally silent, it causes inefficient splicing of exon 7.
Thus, 90% of transcripts generated by SMN2 lack exon 7 and only
10% are full length (Lefebvre et al. 1995; Lorson et al. 1999;
Monani et al. 1999). While full-length SMN2 transcripts produce
a protein identical to SMN1, the ⌬7-SMN2 transcripts encode a
truncated and dysfunctional protein. Increased SMN2 copy number (Wirth et al. 2006) and higher levels of full-length SMN ex-
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pression from SMN2 correlate with milder clinical disease in human patients with SMN1 mutations (Coovert et al. 1997; Lefebvre et al. 1997) and in orthologous mouse models (Monani et al.
2000). The SMN1 gene product, SMN, is a ubiquitously expressed
protein member of multiple ribonucleoprotein complexes with
diverse roles in RNA metabolism, splicing, and transport in all
cells (Meister et al. 2002; Bassell and Kelic 2004). Therefore, a
central focus of SMA research remains to discern the disease
mechanism(s) and thereby to understand why the primary disease pathology is localized to spinal lower motor neurons when
SMN function is vital for all cells.
We recently described a domestic cat model of SMA exhibiting autosomal recessive, juvenile-onset skeletal muscle atrophy
and weakness with onset at ∼12 wk of age due to lower motor
neuron loss (He et al. 2005). The affected cats exhibit progressive
instability with gait and postural abnormalities attributable to
symmetric weakness and atrophy of proximal muscles. Skeletal
muscle atrophy is evident histologically by 3 mo and becomes
palpable by 5 mo of age. In time, more distally placed muscles
may become involved as well. Muscle changes correlate with loss
of spinal lower motor neurons and axons of the ventral horn
roots, but affected cats survive well into adulthood. He et al.
(2005) also reported that SMN was excluded from the feline SMA
disease locus. Thus, the affected cats are similar to type III SMA
patients of the milder phenotype, with onset of signs after having
gained the ability to walk and having two normal copies of
SMN1. By implication, function of the disease gene underlying
feline SMA is essential for lower motor neuron maintenance.
Therefore, we undertook an unbiased whole-genome scan for
linkage to the disorder and here report identification of LIX1, a
gene largely expressed in motor neurons, but of as yet undescribed function, as the putative feline SMA disease gene.

Results
Whole-genome scan and linkage analysis
We genotyped 23 privately owned and 45 purpose-bred members
of a domestic cat SMA pedigree (Fig. 1) with previously mapped,
highly polymorphic short tandem repeat (STR) markers
(Menotti-Raymond et al. 2003a) developed for the Feline Genome Project (http://www.ncbi.nlm.nih.gov/projects/genome/
guide/cat/). As shown in Figure 1, the disorder segregates as an
autosomal recessive trait, and all parents of affected cats can be
traced to a single common ancestor. Therefore, we expected affected cats to be homozygous by descent for the same mutation
and closely flanking marker alleles. We detected significant linkage with marker FCA689 on A1q, subsequently confirmed by
other markers on A1q (Table 1), and multipoint analysis predicted that the cat SMA locus was between FCA071 and FCA770
(peak score 20.1, with all alternate placements scoring at least
one LOD unit less).
Comparison of the published order of feline markers (Murphy et al. 2000; Menotti-Raymond et al. 2003a,b) to the order of
genes in the homologous chromosomal regions of human
(HSA 5q), dog (CFA 3), and mouse (MMU 13) suggested the occurrence of an inversion within the feline disease interval relative
to the other genomes or possible errors in gene order indicated by
the cat radiation hybrid (RH) map. To address these alternative
possibilities, we ordered sequence-tagged sites (STS) of eight protein-coding loci distributed across the region by RH mapping
(Table 1, column 2). Ben-Dor and Chor (1997) had shown theo-

Figure 1. Domestic cat SMA pedigree. Cats above the dashed line were
privately owned, purebred Maine coon cats, and those below were purposely bred for this investigation. Squares indicate males, circles indicate
females, filled symbols indicated cats exhibiting the SMA phenotype, and
half-filled symbols indicate obligate carriers. All cats indicated by numbers
were genotyped, but cat 80 and those numbered >229 were genotyped
only during fine-mapping of the established disease interval. The investigational breeding colony was derived by gamete collection (semen
from cat 58 and oocytes from the unrelated mongrel cat 180), in vitro
fertilization, and embryo transfer.

retically that larger panel sizes produce more robust RH maps, so
the genotyping panel was expanded from 93 to 178 hybrid cell
lines. As shown in Table 1, in the higher resolution RH map, the
SMA disease interval displayed linear syntenic homology with
the comparable region of the human genome (Table 1, column
3). The reordering of type I markers placing HEXB adjacent to
SMN, rather than telomeric of FCA071, was further supported by
comparison of the map to orthologous regions of the dog and
mouse genomes and provided a high degree of confidence in the
marker order across the disease interval.

Deletion abrogating LIX1 and LNPEP expression
For fine mapping the SMA locus, new STR markers within introns
or 2 kb 5⬘ or 3⬘ of six genes in the disease interval were developed
and genotyped in the SMA pedigree (Table 1, columns 4 and 5).
Four markers defining an ∼5.2-Mb interval showed no recombination of alleles with disease locus alleles, but LIX1 was prominent among those because the marker appeared to be homozygous in all 28 SMA carriers and did not amplify in any of the 31
affected cats. These segregating, but nonamplifying allele(s) suggested the existence of a deletion, possibly disrupting LIX1 on
the disease allele. In cats outside of this pedigree, the LIX1 marker
probably behaves as a typical Mendelian microsatellite polymorphism in which alleles are defined by variable numbers of a short
repeat unit. However, carriers in the SMA pedigree appeared to be
homozygous, albeit for different alleles, but this was actually
hemizygosity. In affected cats, no alleles of the LIX1 microsatellite were detected because both copies are deleted, whereas the
other three intragenic microsatellites that had zero recombination (NR2F1, RHOBTB3, RGMB) did amplify in the affected cats.
Because the LIX1 microsatellite was deleted in affected cats,
we avoided the usual challenge of choosing and sequencing positional candidate genes for mutations, but were instead faced
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Table 1. Integrated RH, comparative, and genetic linkage map of
the feline SMA region
RH position in
previous mapa
and as
revised herein

Marker
FCA765
FCA767
EST44
SMN
HEXB
ARSB
FCA689
FCA225
FCA768
CSPG2
FCA071 (MEF2C)
NR2F1
EST46
RHOBTB3
LIX1
RGMB
PAM
EFNA5
CAMK4
FCA770 (NBL4)
FCA771

35.3
(1364.7) binned
(1523.6) 65.6
(1498.5) 84.9
(1493.2) 90.9
(1428.4) 0.0
124.4
(1445.8)
154.7
167.9
186.2
212.1
(1632.2) 230.4
(1620.6) 240.7

HSA 5q
Position
(Mb)

Peak
LOD

 of
peak

55.6
unknown
71.5
69.9
74.1
78.2
79.2
81.8
81.9
82.8
88.2
92.9
93.6
95.1
96.5
98.1
102.3
106.8
110.8
111.5
171.1

0.45
1.61
ND
3.70
NI
NI
7.23
2.52
11.52
NI
17.50
12.73
NI
4.84
18.92
6.02
12.64
15.35
NI
15.36
5.35

0.28
0.18
0.14
0.11
0.08
0.07
0.02
0.00
0.00
0.00
0.00
0.01
0.01
0.04
0.16

Markers are shown in genomic order along FCA A1q as revised in this
publication, except that there was insufficient evidence to order FCA225
relative to FCA768 in the genetic linkage map, and FCA225 was not
placed on the RH map. NR2F1 through EFNA5 represent markers that
were identified as part of this study after multipoint linkage analysis
showed that FCA071 and FCA770 flanked the disease interval. Locus
identifiers in column 1 are in italics when an STR marker used in the
genetic map was within or closely flanked the indicated gene. The relative
marker positions (cR) in the currently revised subregion of the RH map are
shown in column 2 with positions from the previous map (aMenottiRaymond et al. 2003b) shown in parentheses for comparison. Positions of
markers with a blank in column 2 were not determined in that version of
the RH panel. The SMN marker could be binned (placed) immediately
above HEXB in the RH map with an RH LOD score of 2.19 comparing its
best predicted position with its second best (between HEXB and ARSB).
The anomalous RH map position of FCA768 in the second map was due
to low-retention frequency and was inconsistent with the genetic map
order. Column 3 shows the positions of HSA 5q sequences determined by
BLAT analysis to be orthologous to sequences flanking the feline markers.
Peak LOD scores for linkage of polymorphic markers to feline SMA and
the estimated recombination fraction for each are in columns 4 and 5,
respectively. In column 4, NI indicates markers that were monomorphic
and, therefore, not informative in the feline pedigree, and ND indicates a
marker was not assessed genetically in the SMA kindred.

with the challenge of determining the endpoints of the mutation
and supplying further proof that the deletion disrupts LIX1 expression. Fifty-two additional sequence-tagged sites (STS) in LIX1
exons and at regular genomic intervals 3⬘ of LIX1 were analyzed
in affected cat DNA, including the downstream genes LNPEP,
LRAP, ARTS-1, and CAST. A deletion was confirmed, and the
breakpoints were narrowed to intron 3 of LIX1 and intron 1 of
LNPEP (Fig. 2A). LIX1 and LNPEP are transcribed from opposite
strands, their most 3⬘ exons adjacent, so the data indicated loss of
exons 4–6 of LIX1 and all but exon 1 of LNPEP. Based on comparison to the homologous region in the dog genome by BLAT
analysis (http://genome.ucsc.edu/cgi-bin/hgBlat?), we estimated
the deletion at the cat SMA disease locus to be ∼140 kbp. We
identified the precise deletion breakpoints by sequencing the
PCR product amplified from affected cat genomic DNA with
primers flanking the deletion. Two copies of the short sequence,
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AGTTTA, flanked the deletion site, a finding compatible with a
deletion mechanism of nonhomologous recombination (WoodsSamuels et al. 1991).
We confirmed that all 31 affected cats were homozygous for
the deleted allele and all 28 obligate carriers were heterozygous
by multiplex PCR assay amplifying products from each of the
deletion breakpoints on the normal and deleted alleles of FCA
A1q (Fig. 2B). One hundred fifty-two clinically normal purebred
Maine coon cats, the breed from which the feline SMA family was
derived, were heterozygous or homozygous for the normal allele.
RT–PCR analysis demonstrated LIX1 and LNPEP mRNA expression in cervical spinal ventral horn gray matter of genetically
normal and heterozygous carrier cats, but no expression of either
gene was detected in the affected cats (Fig. 2C). Aberrant RNA
transcripts were not observed in affected cat RNA by Northern
blotting (data not shown). These data thus also confirmed that
feline SMA in this kindred is an autosomal recessive trait caused
by disruption of the LIX1/LNPEP locus.

Characterization of LIX1
LNPEP is a well-annotated gene, and based on reported functionality and expression profiles (discussed below), is an unlikely
SMA disease gene. In contrast, LIX1 is poorly annotated; while it
appears to be expressed largely in spinal cord (GNF Gene Expression Atlas 2, UCSC Genome Browser, Human 2004 assembly), its
function is unknown in any species or tissue. Therefore, we undertook initial investigation of feline LIX1. Semi-quantitative
RT–PCR (Fig. 3) and Northern blotting (Fig. 4) demonstrated that
among tissues of juvenile cats, LIX1 mRNA is expressed primarily
in the central nervous system (CNS) and most strongly in spinal
cord. By comparison, LNPEP is more widely expressed and, except for pituitary gland and cerebellum, most strongly in the
thymus, spleen, heart, and adrenal gland.
The nucleotide sequence of LIX1 cDNA amplified from cat
spinal cord demonstrated an open reading frame (ORF) of 846 bp
(GenBank accession no. DQ250154). The deduced amino acid
sequence was 99%, 97%, 97%, 92%, 85%, 59%, and 51% identical to those of dog, cow, human, mouse, chicken, Danio rerio, and
Drosophila melanogaster, respectively, and amino acid substitutions among these species are highly conservative. Protein sequence conservation across this broad range of species suggested
that LIX1 function is essential. Of particular note was that computerized secondary structure analysis predicted amino acid residues 29–99 of LIX1 fold into a double-stranded RNA-binding
domain, a domain common in proteins of RNA metabolism or
transport and previously predicted in CG13139, the Drosophila
LIX1 ortholog (Saunders and Barber 2003).
We observed additional conservation outside of the proteincoding sequence in LIX1 mRNA compatible with conservation of
essential post-transcriptional cis regulatory elements. Sequence
identity was highly concentrated in the ∼400 bp before the start
translation codon (5⬘ UTR), where the cat sequence was 97%,
95%, 95%, 88%, 69%, 52%, and 38% identical to the dog, cow,
human, mouse, frog, chicken, and fruitfly sequences, respectively. In each of the mammals, the degree of nucleotide sequence conservation in the 5⬘ UTR was identical to or greater
than that found in the ORF of LIX1. Included in this conserved
segment are sequences predicted (Zuker 2003) to fold into relatively stable stem–loop structures (initial ⌬G∼50 kcal/mol). In all
but the chicken and fruitfly, these potential stem loops are part
of or preceded by potential upstream ORFs. Examples of each of
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extent of highly conserved sequence in
the 5⬘ UTR also suggest that the 5⬘ UTR is
longer than is annotated in sequences
previously deposited in the GenBank
and UniGene databases, none of which
was determined experimentally.

Survey for human LIX1 mutations
The discovery of LIX1-associated etiology in the feline model raised the question as to its potential role in human
SMA, particularly in cases that lack the
common genetic cause of sequence
variation in SMN1. Although they are
not adjacent, SMN1 and LIX1 are genetically linked ( = 0.25–0.30); so results of
linkage analysis in small SMA families,
even with multiple cases of SMA, might
show no recombination between an inFigure 2. An ∼140-kb deletion abrogates LIX1 and LNPEP expression in SMA affected cats. (A) A
formative marker of SMN1 when the true
schematic of the genomic organization of LIX1 and LNPEP on FCA A1q. Arrows indicate the direction
disease locus is LIX1.
of transcription of each gene. The scale of chromosome coordinates is from the region of conserved
To assess the possibility that mutasynteny in the dog genome (CFA 3) (UCSC Genome Browser; July 2004 assembly). Sequence of the
deleted and normal alleles are aligned showing the precise breakpoints below the schematic. The
tions in LIX1 might also occur in cases of
immediately flanking 6-bp sequence, AGTTTA, is in bold. (Note that the genome browser did not itself
human SMA, we sequenced the LIX1identify exon 1 of LNPEP by homology with RefSeq genes, but limited homology was identified by BLAT
coding regions of 25 unrelated SMA pasearch of the dog genome with a cat sequence that was 82% identical over 300 bp of the human exon
tients (23 exhibited the type III pheno1 and flanking 5⬘-UTR and intron 1 sequences). (B) PCR products produced from genomic DNA in a
multiplex reaction designed to amplify across both deletion breakpoints when the normal allele (lane
type) previously determined to be free of
N) was present. A third product corresponding to the affected cat sequence shown in A amplified when
SMN1 deletions or subtle mutations
the deleted allele was present, either in homozygous affected (lane A) or heterozygous carrier (lane C)
(Wirth et al. 1999). We found that LIX1
cats. (C) RT–PCR products amplified from cervical spinal cord ventral horn RNA of a genetically normal
mRNA expression is undetectable by RT–
cat (lane N), a clinically normal carrier (lane C), and an SMA affected cat (lane A). PCR primers for LIX1
PCR in the human EBV-transformed
were from exons 1 and 4, LNPEP primers were from exons 14 and 15, and GAPDH primers were from
exons 6 and 8.
lymphoblastoid cell lines, so the coding
exons were amplified from whole-blood
genomic DNA of these patients. While
no mutational variant was found in exons or splice-site consenthese kinds of features in mRNA have been implicated in modusus sequences, we cannot conclusively exclude a LIX1 expression
lating transcript stability, translation efficiency, or both (Mendell
defect in these or other non-SMN1 SMA patients until LIX1and Dietz 2001).
expressing tissue can be interrogated. Furthermore, populations
The LIX1 3⬘ UTR sequence is also highly conserved, further
other than that represented by our predominantly Caucasian pasuggesting that post-transcriptional regulation may be an importient sample may have higher prevalence of SMA caused by mutant element of LIX1 expression. The cat 3⬘ UTR sequence was
tations at other loci or undetected SMN1 mutations (Stevens et al.
83%, 75%, 75%, 37%, and 39% identical to the dog, cow, human,
1999).
mouse, and chicken, respectively, after excluding an Alu-J element from the human and two ruminant-specific SINEs from the
cow sequences. The aligned sequences were 2.65–2.93 kb, except
Discussion
for the mouse sequence, which was 1.98 kb. In all but the mouse
and chicken, there were four similarly placed poly(A) addition
We report here the molecular basis of type III SMA without SMN
signals. We demonstrated the alternative use of two poly(A) admutation in a cat model, the determination of which is the first
dition signals in LIX1 mRNA isolated from cat lumbar ventral
discovery of a novel disease gene in the domestic cat by wholehorn by RT–PCR and 3⬘-rapid amplification of cDNA ends (RACE)
genome scan and positional reasoning. Identification of LIX1 as
with polyadenylation beginning 1186 and 2642 bp 3⬘ of the stop
the putative feline SMA gene and having function that is appartranslation codon, respectively. Among the five AAUAAA seently required for motor neuron maintenance are findings of
quences in the cat LIX1 3⬘ UTR, the two we observed being used
potential relevance to human SMA. This success demonstrates
were those that were followed by a GU-rich region immediately
after the polyadenylation site, conforming thereby to the bipartite consensus for efficiently used polyadenylation signals
(Proudfoot 1991). However, multiple-tissue Northern blots revealed only a single mRNA species of 3.9–4.1 kb in each tissue of
Figure 3. Tissue expression of LIX1 and LNPEP. Shown are RT–PCR
a juvenile cat (Fig. 4), compatible with message polyadenylated
products of LIX1 and LNPEP amplified from multiple tissues of a genetiat the most 3⬘ site. This disparity of findings suggests that the
cally normal cat. (Lanes: 1, pancreas; 2, skeletal muscle; 3, fat; 4, liver; 5,
shorter message determined by 3⬘ RACE is either not stable in
spleen; 6, duodenum; 7, kidney cortex; 8, cardiac muscle; 9, adrenal; 10,
these tissues or is not expressed at the developmental stage exthymus; 11, brainstem; 12, cerebellum; 13, brain cortex; 14, thalamus;
15, lumbosacral spinal cord; 16, pituitary; 17, cervical spinal cord.)
amined. The length of the stable LIX1 message and the linear
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Figure 4. LIX1 multiple tissue Northern blot. Twenty micrograms of
total RNA isolated from each normal cat tissue was electrophoresed on a
0.8% formaldehyde-agarose gel, transferred to a nylon membrane, and
hybridized to a random-primed labeled LIX1 cDNA probe that included
280 bp of 5⬘ UTR, the coding region, and 545 bp of 3⬘ UTR. Migration of
RNA molecular weight markers (in kb) is indicated to the left. (Lanes: 1,
thalamus; 2, spinal cord ventral horn; 3, kidney; 4, cardiac muscle; 5,
skeletal muscle).

the current maturity of gene-mapping resources available for this
species (Murphy et al. 2000; Menotti-Raymond et al. 2003a,b) as
well as the utility of 2⳯ whole-genome sequence coverage, even
before assembly.
To date, there are reports of ∼250 spontaneously occurring
pathologies of likely genetic origin in cats (http://omia.angis.
org.au/), and almost all have human counterparts. With the current sophistication of medical monitoring for pet cats, of which
there are ∼90 million in the United States alone (http://www.
appma.org/press_industrytrends.asp), and the inbred nature of
many cat breeds, new disease entities and new cases of previously
described pathologies continue to be ascertained. With the development of genomic resources in the cat and the application of
complementary comparative tools developed in other species,
the domestic cat is emerging as a promising resource of phenotypically defined genetic variation of biomedical significance
(O’Brien et al. 2002). Exploration of similar resources in other
species, particularly the dog and mouse, has provided important
insight into otherwise unexplained biomedical disorders (e.g.,
Lin et al. 1999).
Strictly speaking, the question still remains as to which of
the deleted genes is the SMA disease gene or whether loss of both,
or perhaps of an unidentified nonprotein coding sequence is required to produce the disease. Based on reported functionality
and/or expression profiles, we suggest that LIX1 alone is the disease gene. LNPEP is an aminopeptidase most highly expressed in
placenta, heart, kidney, and small intestine that is variously secreted or a type II membrane protein, both forms having activity
that degrade various peptides, including hormones such as oxytocin and vasopressin (Laustsen et al. 1997). The knockout
mouse model revealed that Lnpep functions in some way to enhance mobilization of the glucose transporter, Glut4, to the cell
surface in response to insulin stimulation, but the Lnpepⳮ/ⳮ mice
did not lose glucose homeostasis (Keller et al. 2002). Although
CNS tissues of the knockout animals were not examined directly,
overt neuromuscular disease was not reported, even though
knockout mice over a year of age were investigated.
While LNPEP does not present a compelling case for significant expression or essential function in spinal cord, LIX1 expression appears to be highest in the spinal cord of humans (http://
genome.ucsc.edu/cgi-bin/hgGene?hgsid=70251085&db=
hg18&hgg_gene=NM_153234). LIX1 was first reported as transiently expressed in the chicken developing limb bud and facial
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primordia, the gene identifier standing for limb expression 1
(Swindell et al. 2001). The only other published report on the
gene demonstrated transient Lix1 mRNA expression in the same
structures as well as in various parts of the CNS in embryonic and
fetal mice (Moeller et al. 2002). There was increasing expression
from late gestation through adulthood in mouse spinal cord and
dorsal root ganglia, with expression in spinal cord restricted to
ventral horn motor neurons and some interneurons. Our data
further indicate that in juvenile cats, expression of LIX1, but not
LNPEP, is found mostly in the CNS and is strongest in spinal
cord.
The high evolutionary conservation of LIX1 suggests that
function of the gene product is essential, and the cat SMA phenotype caused by LIX1 disruption points to an important role in
motor neuron development and/or maintenance. While LIX1
function remains to be determined, this putative disease gene
identified by investigation of the cat SMA model exhibits an
expression profile more restricted to the site of human and cat
pathology than is the expression of SMN1, the most commonly
altered gene in human SMA phenotypes. If the predicted doublestranded RNA-binding domain is a functional domain in this
protein, it suggests that LIX1 may participate in RNA metabolism
or transport, as does SMN (Meister et al. 2002; Bassell and Kelic
2004). One intriguing possibility is that the two gene products
interact in a common pathway of motor neuron maintenance
and that the tissue-specific nature of SMA pathology can be conferred by loss of LIX1 function by mutation at either locus. Determination of LIX1 function may well provide fresh insight into
the mechanism of the disease, impetus for more targeted therapeutics, and answers to fundamental questions of motor neuron
development, maintenance, and/or function.

Methods
Animals and patients
Privately owned, purebred Maine coon cats were investigated as
previously described (He et al. 2005) to determine phenotype.
We established the Michigan State University SMA breeding
colony by semen collection of an affected male Maine coon (cat
58 in Fig. 1), in vitro fertilization of oocytes from a single unrelated domestic cat (cat 180 in Fig. 1), and embryo transfer using
described methods (Swanson 2006). We performed designed
matings, determination of phenotype, and euthanasia according
to protocols approved by the All University Committee for Animal Use and Care of Michigan State University (protocol no.
01/04–014–00) and conforming to National Institutes of Health
guidelines. Subsequently, colony cats mated and gave birth naturally without investigator assistance. To determine the SMA disease phenotype, we observed all colony offspring for clinical
weakness beginning at ∼10 wk and progressing through 5 mo of
age. SMA patients or their parents gave informed consent for
DNA analysis (University of Cologne protocol no. 04–138), according to the principles of the Declaration of Helsinki.

Genotyping
STR markers previously mapped in the cat genome and randomly
distributed across the autosomes were chosen and genotyped as
described (Menotti-Raymond et al. 2003a,b). We developed new
gene-associated STRs for fine-mapping in the disease-interval
(Supplemental Table 2) and STSs for RH and deletion breakpoint
mapping (Supplemental Tables 1 and 3, respectively) by identifying the STRs or orthologous cat coding sequence in the grow-
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ing database of unassembled and unannotated 2⳯ Felis catus
whole-genome shotgun (WGS) sequences (http://www.ncbi.nlm.
nih.gov/blast/tracemb.shtml) by discontiguous MegaBLAST
search (Zhang et al. 2000) with human or dog gene plus flanking
sequence. To facilitate STS mapping and to construct a partial
sequence assembly of LIX1, LNPEP, and the region between
them, sequence similarity and overlap of sequences were determined with MegaBLAST (Zhang et al. 2000) and BLASTn
(Altschul et al. 1997). Overlapping sequences were ordered and
oriented to reflect the order and orientation found on HSA 5 and
CFA 3. These were assembled into contigs using the TPF processor (http://www.ncbi.nlm.nih.gov/projects/zoo_seq/) with additional instructions to the processor to force overlaps considered
valid despite low-quality end sequence.

5⬘-GCTACAGCCACCACGTCAGAGTT-3⬘, respectively; and for
GAPDH exons 6 and 8 were 5⬘-TCATCTCTGCCCCTTCTGCTG
AT-3⬘ and 5⬘-ATTCAGCTCTGGGATGACCTTGC-3⬘, respectively.
Thermocycling was as above except that we performed these PCR
reactions in 20-µL reactions for 30 cycles and the annealing temperature was 58°C. “No-RT” negative controls were included for
all reactions.
The LIX1 mRNA sequence was determined by standard automated dideoxy chain termination cycle sequencing methods of
RT–PCR products amplified from cat spinal cord RNA. We assembled overlapping sequences and carried out sequence analysis with the Lasergene suite of programs (DNAstar). Northern
blots were prepared by standard protocols (Sambrook and Russell
2001), and 3⬘-RACE was performed according to the kit manufacturer’s instructions (Invitrogen).

Linkage analysis
We performed linkage computations with the Superlink program
(Fishelson and Geiger 2004; available for download at http://
bioinfo.cs.technion.ac.il/superlink) using assumptions of 0.001
disease allele frequency, simple recessive inheritance with full
penetrance, and equal marker allele frequencies. Recombination
fractions were estimated to within 0.01. Once we found an apparently linked marker, we used the existing cat maps (MenottiRaymond et al. 2003a,b) to select nearby microsatellite markers
for fine-mapping. For multipoint linkage analysis, intermarker
genetic distances were estimated from the data on the SMA pedigree, and we used a 1-LOD unit support heuristic to determine
the optimal marker order. Allele data for FCA microsatellites
typed in the SMA pedigree and appearing in Table 1 are available
at ftp://ftp.ncbi.nlm.nih.gov/pub/catSMA.

Radiation hybrid mapping
A radiation hybrid map of the portion of FCA A1q linked to the
disease locus was computed using the software packages rh_tsp_
map (Agarwala et al. 2000), CONCORDE (Applegate et al. 1998),
and QSopt (http://www.isye.gatech.edu/∼wcook/qsopt) using
the maximum likelihood criterion and the known reduction of
the radiation hybrid mapping problem to the traveling salesman
problem. We used methods similar to those used for the latest
full cat map (Menotti-Raymond et al. 2003a) with the notable
exceptions that we used vectors of size 178 (Murphy et al. 1999)
and excluded markers with more than two uncertain entries. A
flips test with window size 8 demonstrated that the determined
marker order was at least three LOD units better than any alternative.

Mutation and gene expression analysis
We performed multiplex PCR analysis of SMA alleles using two
primers flanking the deletion breakpoint in intron 3 of LIX1 and
two flanking the deletion breakpoint in intron 1 of LNPEP. PCR
reactions were 50 µL using primers 5⬘-TGGAGAGTGTGCAG
GAAGCAGT-3⬘, 5⬘-TGGTGATCAAGGGCGTCTAAAA-3⬘, 5⬘CGTCTGAGGTGTGGCTTGTCAG-3⬘, and 5⬘- TTTGGCCTTGA
AGACCGCTAAA-3⬘, ∼200 ng genomic DNA template, 2.5 mM
each dNTP, 1.5 mM MgCl2, and 0.5 U Amplitaq DNA polymerase
(Roche Diagnostics). Thermocycling was 35 cycles of 94°C and
62°C, each for 30 sec, and 72°C for 2 min.
Gene expression was analyzed by RT–PCR as previously described (He et al. 2005) using equal amounts of total RNA from
multiple tissues isolated with Trizol (Invitrogen) according to the
manufacturer’s protocol. PCR primers for cat LIX1 exons 1 and 4
were 5⬘-ACTGCAAGAATTCAGGCATGAGG-3⬘ and 5⬘-TA
GTGGTAGGCTCCAATGCTGGT-3⬘, respectively; for LNPEP exons 14 and 18 were 5⬘-TCTTTGATGATTGGGTGGCATCT-3⬘ and

Primary and secondary protein structure prediction
We used the MegAlign program (DNAstar) to compare the deduced Cat LIX1 amino acid sequence with those of other species
found in GenBank. Secondary-structure prediction was carried
out using the four best-validated (Koh et al. 2003) prediction
servers, PsiPRED, SABLE2, SAM-T2K, and PROFsec (http://
cubic.bioc.columbia.edu/eva/sec/pairwise.html). Results were
parsed, formatted, and visualized using in-house software (covered by the GNU General Public License and publicly available at
http://proteins.msu.edu/Servers/Secondary_Structure/
visualize_secondary_structure_predictions.html).

Human LIX1 sequencing
We amplified each LIX1 exon separately by PCR from SMA patient genomic DNA. Primer sequences are in Supplemental Table
4. Thermocycling was 31 cycles of 94°C for 15 sec, 55°C (63°C for
exon 6) for 15 sec, and 72°C for 30 sec. PCR products were sequenced with dideoxy chain termination cycle sequencing methods.
RT–PCR analysis of RNA isolated from EBV-transformed
lymphoblastoid cell lines of SMA patients was performed using
the primers 5⬘-GATCCGGCTCTAGTCTTCAAA-3 and 5⬘-CCT
CAGGGCCATTCGTAGC-3⬘ in exons 1 and 6, respectively. Positive controls included RT–PCR amplification of GAPDH and
SFRS10 (Htra2-␤) cDNA products from the sample lymphoblast
RNA as well as LIX1 from RNA isolated from fetal human spinal
cord.
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